The PIK3CA gene is mutated in nearly 40% of women with HR+/HER2- metastatic breast cancer and abnormal signaling in the PIK3CA pathway is related to tumorigenesis, progression, and therapeutic ...
Eight hundred and six patients were randomly assigned (2:1). Tumors were analyzed using the Myriad MyChoice HRD Plus assay to assess non–BRCA HRRm and HRD status; HRD was based on a genomic ...
In a recent study published in The Lancet Regional Health-Southeast Asia, researchers developed an artificial intelligence (AI)-based predictive system (AIPS) model for the early detection of lung ...
Scrambling for BRAF Mutation Status in Patients with Melanoma: Is It Really Necessary to Initiate Treatment? The following represents disclosure information provided by authors of this manuscript. All ...
Analysis of a real-world database showed that an EGFR exon 20 mutation occurred in fewer than 17% of patients with non-squamous NSCLC. Of patients with the mutation, fewer than 1% had an EGFR exon ...
The Times of Israel on MSN
Health Ministry said to flag error in genetic test kit detecting rare mutation, reread results
Haaretz report concerns MECR mutation, part of Israel’s expanded screening panel; can lead to problems with movement, speech, ...
Litron laboratories developed the Pig-a gene mutation assay as a means to simply and reliably evaluate the potential mutagenicity of compounds. Commercially available from Litron Laboratories under ...
The Times of Israel on MSN
Health Ministry flags error in genetic test kits detecting rare mutation
The post Health Ministry flags error in genetic test kits detecting rare mutation appeared first on The Times of Israel.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback